B of A Securities Maintains Buy on Hims & Hers Health, Raises Price Target to $25
Portfolio Pulse from Benzinga Newsdesk
B of A Securities analyst Michael Cherny has maintained a Buy rating on Hims & Hers Health and raised the price target from $23 to $25.
October 21, 2024 | 11:59 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
B of A Securities has reaffirmed its Buy rating on Hims & Hers Health and increased the price target from $23 to $25, indicating positive expectations for the company's stock performance.
The increase in price target from $23 to $25 by B of A Securities suggests a positive outlook for Hims & Hers Health, likely boosting investor confidence and potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100